{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:27:45Z","timestamp":1773235665100,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jsat.2012.08.007","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T02:16:17Z","timestamp":1349144177000},"page":"424-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Concurrent group treatment for hepatitis C: Implementation and outcomes in a methadone maintenance treatment program"],"prefix":"10.1016","volume":"43","author":[{"given":"Melissa R.","family":"Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene J.","family":"Soloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S.","family":"Jefferson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Roose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia H.","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain H.","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2012.08.007_bb0005","first-page":"187","article-title":"The prevalence of hepatitis C virus infection in the United States 1999 through 2002","volume":"138","author":"Armstrong","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1016\/j.jsat.2012.08.007_bb0010","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1086\/425361","article-title":"Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users","volume":"39","author":"Backmund","year":"2004","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2012.08.007_bb0020","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1572-0241.2005.41860.x","article-title":"Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection","volume":"100","author":"Bini","year":"2005","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.jsat.2012.08.007_bb0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3949\/ccjm.71.5.369","article-title":"Shared medical appointments: Increasing patient access without increasing physician hours","volume":"71","author":"Bronson","year":"2008","journal-title":"Cleveland Clinic Journal of Medicine"},{"key":"10.1016\/j.jsat.2012.08.007_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jsat.2006.02.006","article-title":"Characteristics of substance abuse treatment programs providing services for HIV\/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network","volume":"30","author":"Brown","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2012.08.007_bb0035","doi-asserted-by":"crossref","first-page":"S362","DOI":"10.1086\/427454","article-title":"Integrating treatment for hepatitis C virus infection into an HIV clinic","volume":"16","author":"Clanon","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2012.08.007_bb0040","first-page":"73","article-title":"Experience of hepatitis C among current or former heroin users attending general practice","volume":"98","author":"Cullen","year":"2005","journal-title":"Irish Medical Journal"},{"key":"10.1016\/j.jsat.2012.08.007_bb0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM200107193450312","article-title":"Treatment of chronic hepatitis C in active drug users","volume":"345","author":"Davis","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2012.08.007_bb0050","first-page":"23","article-title":"Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City","volume":"9","author":"Diaz","year":"2001","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2012.08.007_bb0055","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1086\/427446","article-title":"Knowledge and attitudes about treatment for hepatitis C infection and barriers to treatment among current infection drug users in Australia","volume":"40","author":"Doab","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1016\/j.jsat.2012.08.007_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"Management of hepatitis C virus infection\u2014European Association for the Study of the Liver","volume":"55","author":"EASL Clinical Practice Guidelines","year":"2011","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jsat.2012.08.007_bb0070","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1086\/427441","article-title":"Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users","volume":"40","author":"Edlin","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2012.08.007_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJM200107193450311","article-title":"Is it justifiable to withhold treatment for hepatitis C from illicit-drug users","volume":"345","author":"Edlin","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2012.08.007_bb0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7326\/0003-4819-136-4-200202190-00008","article-title":"Surprisingly small effect of antiviral treatment in patients with hepatitis C","volume":"136","author":"Falck-Ytter","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2012.08.007_bb0085","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/hep.23429","article-title":"Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients","volume":"51","author":"Feuerstadt","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jsat.2012.08.007_bb0090","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.qai.0000131932.21612.49","article-title":"Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection","volume":"37","author":"Fishbein","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.jsat.2012.08.007_bb0095","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guidelines by the American Association for the Study of Liver Diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jsat.2012.08.007_bb0100","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management and treatment of hepatitis C, an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jsat.2012.08.007_bb0105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5694\/mja12.10014","article-title":"Hepatitis C treatment outcomes in Australian clinics","volume":"196","author":"Gidding","year":"2012","journal-title":"The Medical Journal of Australia"},{"key":"10.1016\/j.jsat.2012.08.007_bb0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.drugpo.2007.01.009","article-title":"Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection","volume":"18","author":"Grebely","year":"2007","journal-title":"The International Journal on Drug Policy"},{"issue":"3","key":"10.1016\/j.jsat.2012.08.007_bb0115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MEG.0b013e32832a8c4c","article-title":"Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: A novel model incorporating multidisciplinary care and peer support","volume":"22","author":"Grebely","year":"2011","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.jsat.2012.08.007_bb0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.drugalcdep.2009.09.015","article-title":"Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study","volume":"107","author":"Grebely","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2012.08.007_bb0125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2893.2009.01080.x","article-title":"Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents","volume":"16","author":"Grebely","year":"2009","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.jsat.2012.08.007_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1360-0443.2006.01698.x","article-title":"Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes","volume":"102","author":"Guadagnino","year":"2007","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.jsat.2012.08.007_bb0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/600304","article-title":"Hepatitis C treatment for injection drug users: A review of the available evidence","volume":"49","author":"Hellard","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2012.08.007_bb0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3122\/jabfm.19.3.276","article-title":"Group visits: A qualitative review of current research","volume":"19","author":"Jaber","year":"2006","journal-title":"Journal of the American Board of Family Medicine"},{"issue":"6","key":"10.1016\/j.jsat.2012.08.007_bb0145","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.21927","article-title":"Predictors of treatment in patients with chronic hepatitis C infection\u2014Role of patient versus nonpatient factors","volume":"46","author":"Kanwal","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jsat.2012.08.007_bb0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ajg.2010.430","article-title":"Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: A national study","volume":"106","author":"Kramer","year":"2011","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.jsat.2012.08.007_bb0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1037\/0893-164X.11.4.211","article-title":"Introduction to the special issue: The National Institute on Drug Abuse's (NIDA's) Drug Abuse Treatment Outcome Study (DATOS)","volume":"11","author":"Leshner","year":"1997","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.jsat.2012.08.007_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2008.09.009","article-title":"Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program","volume":"37","author":"Litwin","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2012.08.007_bb0165","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1086\/427450","article-title":"Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities","volume":"40","author":"Litwin","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1016\/j.jsat.2012.08.007_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","article-title":"The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007","volume":"156","author":"Ly","year":"2012","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2012.08.007_bb0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3816\/SCT.2006.n.003","article-title":"Group medical appointments: Organization and implementation in the bone marrow transplantation clinic","volume":"3","author":"Meehan","year":"2006","journal-title":"Supportive Cancer Therapy"},{"key":"10.1016\/j.jsat.2012.08.007_bb0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","article-title":"Limited uptake of hepatitis C treatment among injection drug users","volume":"33","author":"Mehta","year":"2008","journal-title":"Journal of Community Health"},{"key":"10.1016\/j.jsat.2012.08.007_bb0190","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/QAD.0b013e32801086da","article-title":"Limited effectivelness of antiviral treatment for hepatitis C in an urban HIV clinic","volume":"20","author":"Mehta","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jsat.2012.08.007_bb0195","first-page":"327","article-title":"Mutual mistrust in the medical care of drug users","volume":"17","author":"Merrill","year":"2002","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2012.08.007_bb0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2105\/AJPH.92.3.385","article-title":"Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities","volume":"92","author":"Murrill","year":"2002","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2012.08.007_bb0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1310\/86XW-Y6PX-TNE7-YM7J","article-title":"National Institutes of Health Consensus Development Conference Statement Management of Hepatitis C: 2002 June 10\u201312, 2002","volume":"4","author":"National Institutes of Health","year":"2003","journal-title":"HIV Clinical Trials"},{"key":"10.1016\/j.jsat.2012.08.007_bb0215","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2012.08.007_bb0220","first-page":"58","article-title":"Will drop-in medical appointments (DIGMAs) work in practice?","volume":"3","author":"Noffsinger","year":"1999","journal-title":"Permanente Journal"},{"key":"10.1016\/j.jsat.2012.08.007_bb0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-7517-5-8","article-title":"The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users","volume":"5","author":"Norman","year":"2008","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.jsat.2012.08.007_bb0230","first-page":"889","article-title":"Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection","volume":"165","author":"Patrick","year":"2001","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.jsat.2012.08.007_bb0235","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11524-007-9180-8","article-title":"Offers of hepatitis C care do not lead to treatment","volume":"84","author":"Schackman","year":"2007","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.jsat.2012.08.007_bb0240","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C infection","volume":"5","author":"Shepard","year":"2005","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.jsat.2012.08.007_bb0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0376-8716(00)00144-7","article-title":"Hepatitis C disease among injection drug users: knowledge, percieved risk and willingness to receive treatment","volume":"61","author":"Stein","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2012.08.007_bb0250","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.285.8.1003","article-title":"Former addicts face barriers to treatment for HCV","volume":"285","author":"Stephenson","year":"2001","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2012.08.007_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1472-6963-7-39","article-title":"Drug treatment program patients\u2019 hepatitis C virus (HCV) education needs and their use of available HCV education services","volume":"7","author":"Strauss","year":"2007","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.jsat.2012.08.007_bb0260","series-title":"Results from the 2003 National Survey on Drug Use and Health: National Findings","author":"Substance Abuse and Mental Health Services Administration (SAMSHA)","year":"2004"},{"key":"10.1016\/j.jsat.2012.08.007_bb0265","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1086\/427447","article-title":"Treating hepatitis C virus infection in active substance users","volume":"40","author":"Sylvestre","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2012.08.007_bb0270","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drugpo.2007.01.010","article-title":"Integrating HCV services for drug users: A model to improve engagement and outcomes","volume":"18","author":"Sylvestre","year":"2007","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.jsat.2012.08.007_bb0275","article-title":"Assessment of hepatitis C virus attitudes towards treatment among methadone maintenance treatment program staff","author":"Talal","year":"2010"},{"key":"10.1016\/j.jsat.2012.08.007_bb0280","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1071\/AH080570","article-title":"Drug treatment client's readiness for hepatitis C treatment: Implications for expanding treatment services in drug and alcohol settings","volume":"32","author":"Treloar","year":"2008","journal-title":"Australian Health Review"},{"key":"10.1016\/j.jsat.2012.08.007_bb0290","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jsat.2004.12.004","article-title":"Knowledge of and interest in hepatitis C treatment at a methadone clinic","volume":"28","author":"Walley","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2012.08.007_bb0295","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2105\/AJPH.90.10.1562","article-title":"Estimating future hepatitis C morbidity, mortality and cost in the United States","volume":"90","author":"Wong","year":"2000","journal-title":"American Journal of Public Health"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547212001420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547212001420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:37:00Z","timestamp":1760038620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547212001420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0740547212001420"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2012.08.007","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent group treatment for hepatitis C: Implementation and outcomes in a methadone maintenance treatment program","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2012.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}